Spandidos Publications style
Sugita S, Kawashima H, Tanaka T, Kurisu T, Sugimura K and Nakatani T: Effect of type I growth factor receptor tyrosine kinase inhibitors on phosphorylation and transactivation activity of the androgen receptor in prostate cancer cells: Ligand-independent activation of the N-terminal domain of the androgen receptor. Oncol Rep 11: 1273-1279, 2004.
APA
Sugita, S., Kawashima, H., Tanaka, T., Kurisu, T., Sugimura, K., & Nakatani, T. (2004). Effect of type I growth factor receptor tyrosine kinase inhibitors on phosphorylation and transactivation activity of the androgen receptor in prostate cancer cells: Ligand-independent activation of the N-terminal domain of the androgen receptor. Oncology Reports, 11, 1273-1279. https://doi.org/10.3892/or.11.6.1273
MLA
Sugita, S., Kawashima, H., Tanaka, T., Kurisu, T., Sugimura, K., Nakatani, T."Effect of type I growth factor receptor tyrosine kinase inhibitors on phosphorylation and transactivation activity of the androgen receptor in prostate cancer cells: Ligand-independent activation of the N-terminal domain of the androgen receptor". Oncology Reports 11.6 (2004): 1273-1279.
Chicago
Sugita, S., Kawashima, H., Tanaka, T., Kurisu, T., Sugimura, K., Nakatani, T."Effect of type I growth factor receptor tyrosine kinase inhibitors on phosphorylation and transactivation activity of the androgen receptor in prostate cancer cells: Ligand-independent activation of the N-terminal domain of the androgen receptor". Oncology Reports 11, no. 6 (2004): 1273-1279. https://doi.org/10.3892/or.11.6.1273
